Naproxcinod

Related by string. naproxcinod * * Beyond naproxcinod NicOx . naproxcinod NicOx pipeline . naproxcinod proprietary . lead compounds naproxcinod . naproxcinod capsules *

Related by context. All words. (Click for frequent words.) 73 Dapagliflozin 72 Archexin 72 Cyclooxygenase Inhibiting Nitric Oxide 71 Tezampanel 71 Dasatinib 70 sodium glucose cotransporter 70 Saxagliptin 70 Ambrisentan 70 Mipomersen 70 COX Inhibiting Nitric Oxide 70 TRO# 70 Pirfenidone 70 PDE4 inhibitor 70 Dalbavancin 69 Dabigatran etexilate 69 PRT# 69 oral salmon calcitonin 69 Aliskiren 69 Meets Primary Endpoint 69 metaglidasen 69 Panzem R 69 LibiGel ® 69 TBC# 69 oral rivaroxaban 69 Romidepsin 68 Factor Xa inhibitor 68 HuMax EGFr 68 QNEXA 68 Tablets #mg [002] 68 Raltegravir 68 Aflibercept 68 selective androgen receptor modulator 68 Boceprevir 68 anticancer compound 68 Pivotal Phase III 68 eltrombopag 68 Toremifene 68 R#/MEM # 68 Elagolix 68 diabetic neuropathic pain 68 Ticagrelor 68 Romiplostim 68 BAY #-# 68 BYETTA ® 68 Tesetaxel 68 liposomal formulation 68 Linaclotide 68 Investigational Compound 68 RLY# 67 Tasimelteon 67 Nexavar ® 67 Rivaroxaban 67 Varespladib 67 Elesclomol 67 highly selective inhibitor 67 Phase IIb Trial 67 Phase 2a Clinical Trial 67 DU #b 67 direct renin inhibitor 67 CINOD 67 Elvitegravir 67 TPI ASM8 67 pan HDAC inhibitor 67 Muraglitazar 67 mTOR inhibitor 67 Cannabinor 67 Febuxostat 67 Maribavir 67 Carfilzomib 67 angiotensin receptor blocker ARB 67 Bicifadine 67 Rotigotine 67 torezolid phosphate 67 CDP# 67 Ophena TM 67 Lixisenatide 67 Darusentan 67 Epanova 67 JAK Inhibitor 67 Eltrombopag 67 rosuvastatin calcium 67 Aegerion 66 davalintide 66 ALGRX 66 Oral Insulin 66 bazedoxifene 66 Ranolazine 66 YONDELIS 66 DCCR 66 Bazedoxifene 66 Vilazodone 66 NVA# 66 RhuDex ® 66 acyclovir Lauriad R 66 Vernakalant 66 2 methoxyestradiol 66 Randomized Phase 66 Valsartan 66 Initiate Phase 66 mGluR5 negative 66 mertansine 66 Traficet EN 66 Amrubicin 66 Silodosin 66 Laquinimod 66 LAF# 66 TNF Tumor Necrosis Factor 66 ZOLINZA 66 Panzem R NCD 66 Sym# 66 Cetrorelix 66 Menerba 66 Pivotal Phase 66 Personalized Immunotherapy 66 Angiocept 66 LEVADEX TM 66 Corlux 66 sorafenib Nexavar 66 Iloperidone 66 Ustekinumab 66 Trandolapril 66 Sitagliptin 66 Avanafil 66 oral prodrug 66 selective estrogen receptor modulator 66 MoxDuo IR 66 Lubiprostone 66 octreotide acetate 66 Phase III Clinical Trial 66 PSN# [001] 66 evaluating tivozanib 66 rabeprazole 66 inhaled formulation 66 oral renin inhibitor 66 sorafenib tablets 66 INCB# [001] 66 Golimumab 66 Anavex #-# 66 nucleoside analog 66 Ketotransdel 66 AEGR 66 SNT MC# 66 oral anticoagulant 65 Daclizumab 65 Fulvestrant 65 vascular disrupting agent 65 SUTENT ® 65 rasagiline tablets 65 QNEXA ® 65 KRN# 65 Phase 2a Study 65 Initiates Phase III 65 Vildagliptin 65 Pertuzumab 65 cediranib 65 midstage clinical 65 Pazopanib 65 Talabostat 65 renin inhibitor 65 elotuzumab 65 tezampanel 65 Vidaza R 65 ACOMPLIA R 65 Lodotra TM 65 Solulin 65 Safinamide 65 Fx #A 65 tenofovir emtricitabine 65 Vicriviroc 65 Bayer Onyx 65 generation Hsp# inhibitor 65 Pafuramidine 65 Ropinirole 65 PSN# [002] 65 cathepsin K inhibitor 65 non nucleoside inhibitor 65 ocular formulation 65 Pulmonary Arterial Hypertension 65 Nanobody 65 Zileuton 65 Tasigna nilotinib 65 Pimavanserin 65 Pegloticase 65 LymphoStat B belimumab 65 Initiates Enrollment 65 xanthine oxidase inhibitor 65 DDP# 65 ganetespib 65 Liraglutide 65 liprotamase 65 Nitazoxanide 65 ISIS # 65 AEG# 65 Androxal ® 65 Tekamlo 65 PEGylated anti 65 Serdaxin ® 65 Exforge HCT 65 Aganocide 65 reslizumab 65 NV1FGF 65 generation purine nucleoside 65 seliciclib CYC# 65 Annamycin 65 PHX# 65 teriflunomide 65 Phase 2b Clinical Trial 65 ZK EPO 65 anti amnesic 65 Tyrima 65 Methylnaltrexone 65 Donating CINOD class 65 CCX# B 65 Icatibant 65 Sapacitabine 65 delivers fluocinolone acetonide FA 65 Hsp# Inhibitor 65 BAL# [002] 65 Fluconazole 65 QVA# 65 QRxPharma 65 Voreloxin 65 Ganciclovir 65 Inhalation Solution 65 Telbivudine 65 FOLOTYN ® 65 GW# [003] 65 Bortezomib 65 Clevudine 65 Zorbtive TM 65 antiplatelet agent 65 Tanespimycin 65 IRX 2 65 CTAP# Capsules 65 Vandetanib 64 virus HCV protease inhibitor 64 Civacir 64 azilsartan medoxomil 64 Ramipril 64 Alocrest 64 Lu AA# 64 IMA# 64 Rebif ® 64 omacetaxine mepesuccinate 64 Zingo TM 64 Actemra tocilizumab 64 phase IIa clinical 64 Omacetaxine 64 Betaferon R 64 ISENTRESS raltegravir 64 Phenoptin 64 Glufosfamide 64 LY# [003] 64 Ozarelix 64 TAFA# 64 RAPAFLO 64 Phase III Clinical Trials 64 JAK inhibitor 64 proteasome inhibitor 64 pertuzumab 64 Perifosine 64 orally administered inhibitor 64 TLK# 64 Orazol 64 Fluticasone 64 Milnacipran 64 Anidulafungin 64 Mirapexin 64 PEG SN# 64 Combination REOLYSIN R 64 Initiated Phase 64 Aplidin 64 sunitinib malate 64 Nanobody ® 64 CORT # 64 ALN PCS 64 Novel Antibiotic 64 AstraZeneca Symbicort 64 HFA MDI 64 SAR# [004] 64 Aviptadil 64 Blinatumomab 64 Mycamine 64 5 HT3 antagonist 64 Radezolid 64 alvimopan 64 CB2 selective receptor agonist 64 Xeloda ® 64 delafloxacin 64 Pivotal Study 64 orBec 64 tiapamil 64 Clinical Trial Results 64 tocilizumab 64 EndoTAG TM -1 64 aleglitazar 64 oral proteasome inhibitor 64 Phase III Trials 64 AZILECT R 64 Argatroban 64 briakinumab 64 Ferumoxytol 64 phase IIb 64 obatoclax 64 Inhalation Aerosol 64 Nexavar sorafenib tablets 64 Patient Enrollment 64 renin inhibitors 64 Azedra 64 tanespimycin 64 Medoxomil 64 MAGE A3 ASCI 64 Diamyd R 64 SAR# [002] 64 receptor tyrosine kinase inhibitor 64 Initiates Clinical 64 AAG geldanamycin analog 64 ELND-#/AZD-# 64 IMiDs R 64 Denufosol 64 casopitant 64 Azacitidine 64 radiation sensitizer 64 angiogenesis inhibitor 64 Randomized Double blind 64 selective A2A adenosine receptor 64 topical NSAID 64 IMiDs ® 64 investigational pharmacologically unique 64 candesartan cilexetil 64 rilonacept 64 Hycamtin 64 Rosuvastatin 64 MEVACOR 64 PROVENGE sipuleucel T 64 Spiegelmer ® 64 Tarceva TM 64 VitiGam 64 XYOTAX TM 64 Carvedilol 64 Lysteda 64 CIMZIA TM 64 ADP receptor antagonist 64 6R BH4 64 romidepsin 64 Firazyr 64 Oral Spray 64 ospemifene 64 Rigel R# 64 Enoxaparin 64 Extended Release Tablets 64 photoprotective drug 64 Bremelanotide 64 Lacosamide 64 Exenatide 64 Zoloft sertraline 64 Tykerb lapatinib 64 Aztreonam 64 Xyzal R 63 phase IIb clinical 63 First Patient Dosed 63 IV APAP 63 CCR9 antagonist 63 lamotrigine Lamictal 63 LT NS# 63 PF # [002] 63 Levetiracetam 63 Locteron ® 63 vorinostat 63 Tesamorelin 63 thymalfasin 63 allosteric modulator NAM 63 dihydrochloride 63 Transdermal Patch 63 RhuDex 63 Zolinza 63 Relovair 63 Valdoxan 63 KNS # 63 intranasal formulation 63 Bevirimat 63 Oral Fingolimod 63 Microplasmin 63 Guanilib 63 Nexavar sorafenib 63 Olmesartan 63 immunotherapeutic agent 63 OMP #M# 63 Regeneron Pharma 63 Maraviroc 63 Celebrex celecoxib 63 ONCONASE R 63 vascular disrupting agents 63 Aceon 63 ONGLYZA ™ 63 nucleotide analogue 63 alvespimycin 63 Tekturna HCT 63 CEQ# 63 VA# [002] 63 OncoVEX GM CSF 63 Herceptin trastuzumab 63 CCR5 antagonist 63 targeted radiotherapeutic 63 Prograf ® 63 NXL# 63 Bosutinib 63 Natalizumab 63 Temsirolimus 63 methylnaltrexone bromide 63 MKC# MT 63 protein tyrosine phosphatase 1B 63 roflumilast 63 Granulocyte Colony Stimulating Factor 63 Telmisartan 63 MKC# MKC# PP 63 PEGylated interferon 63 non porcine pancreatic 63 Recombinant Human 63 GLPG# 63 Pralatrexate 63 Ramelteon 63 novel prodrug 63 BZL# 63 TMC# [002] 63 Fidaxomicin 63 muraglitazar 63 esomeprazole Nexium 63 GSK# [002] 63 LCP AtorFen 63 Azilect ® 63 Aurora Kinase 63 novel VDA molecule 63 TriRima 63 Anacetrapib 63 oral ridaforolimus 63 Fondaparinux 63 silodosin 63 Glatiramer Acetate 63 selective estrogen receptor 63 Xanafide 63 Lenalidomide 63 Fosphenytoin 63 balsalazide tablet 63 SGLT2 inhibitor 63 epothilones 63 atrasentan 63 Apixaban 63 Enbrel etanercept 63 aclidinium bromide 63 INT# [002] 63 SinuNase TM 63 peptidic compound 63 Investigational Drug 63 dasatinib Sprycel ® 63 oxaliplatin Eloxatin 63 abatacept Orencia 63 compound INCB# 63 Phase III Trial 63 Telaprevir 63 Phase III ADT 63 PRN FDA Approves 63 QAB# 63 GLYX 63 HCV protease inhibitor 63 pioglitazone HCl 63 Ridaforolimus 63 SERMs 63 Arikace 63 iniparib 63 Desmoteplase 63 Crestor rosuvastatin 63 Drug Candidate 63 IAP inhibitors 63 docetaxel Taxotere R 63 Lodotra 63 Qutenza TM 63 Gabapentin GR 63 modulator SERM 63 Serostim ® 63 beta 1a 63 PEGylated Fab fragment 63 HuMax CD4 63 Erlotinib 63 Roche Actemra 63 Panzem 63 Serdaxin 63 ThGRF 63 Dyloject TM 63 DPP4 inhibitor 63 indacaterol 63 ALN HPN 63 miconazole Lauriad 63 Copegus ribavirin 63 Melphalan 63 investigational humanized monoclonal antibody 63 RGB # 63 FM VP4 63 SPRYCEL ® 63 Torisel 63 albiglutide 63 MTP inhibitor 63 Onconase 63 subcutaneously administered 63 Vertex telaprevir 63 ACTEMRA TM 63 insulin sensitizer 63 NOX E# 63 Soriatane 63 Exelixis compounds 63 Pradaxa ® 63 IAP inhibitor 63 diarrhea predominant irritable 63 tasocitinib 63 riociguat 63 SIMCOR 63 regorafenib 63 Zemplar Capsules 63 Perindopril 63 small molecule thrombopoietin 63 Mg Usa 63 Antitumor Activity 63 Mycophenolate Mofetil 63 lomitapide 63 ACAPODENE 63 HGS# 63 ATL# [001] 63 Initiates Phase II 63 Tyvaso 63 Azedra TM 63 avanafil 63 trastuzumab Herceptin 63 oral picoplatin 63 investigational oral 63 Clolar ® 63 INCB# [002] 63 Arixtra 63 Elotuzumab 62 Proquin XR 62 ILUVIEN ® 62 Frova ® 62 non peptidic protease 62 selective kinase inhibitor 62 Generic Version 62 dyskinesia PD LID 62 CombAT 62 HMG CoA reductase inhibitors 62 PrevOnco 62 Darinaparsin 62 Bavituximab 62 nilotinib Tasigna 62 CYT# potent vascular disrupting 62 ELND# 62 CG# [003] 62 Pruvel 62 Omnitarg 62 orally bioavailable 62 Phase 2a Trial 62 Hycamtin ® 62 ELACYT 62 Piperacillin 62 RANK Ligand inhibitor 62 IL# PE#QQR 62 RSD# 62 radezolid 62 Androxal TM 62 generation antisense 62 GATTEX TM 62 fenofibric acid 62 Celgene Revlimid 62 Ixempra 62 Empatic TM 62 Ceflatonin R 62 Initiate Clinical Trial 62 Zenpep 62 Degludec 62 Rasilez ® 62 MEK Inhibitor 62 AZILECT ® 62 FIRMAGON R 62 Triolex 62 omalizumab Xolair 62 Plicera 62 Phase 2b Trial 62 phase IIb trial 62 Pravachol pravastatin 62 PRTX 62 novel nucleoside analog 62 pegylated interferons 62 Onrigin 62 Rasagiline 62 novel synthetic PEGylated 62 Adentri 62 Zarnestra 62 metastatic castration resistant 62 Completes Patient Enrollment 62 Investigational Treatment 62 MEK inhibitor 62 albinterferon alfa 2b 62 Benazepril 62 leading oral taxane 62 BRILINTA 62 selective orally bioavailable 62 Cethromycin 62 cetuximab Erbitux R 62 Orally administered 62 Nexium esomeprazole 62 Acapodene 62 Neurodex 62 Levoleucovorin 62 aliskiren 62 hyaluronidase enzyme 62 PNP inhibitor 62 Chemophase 62 TREDAPTIVE 62 APEX PD 62 Candesartan 62 ELIQUIS 62 IMiD 62 Tamsulosin 62 Onbrez Breezhaler 62 Extended Release 62 DermaVir Patch 62 SCH # 62 aripiprazole Abilify 62 FTY# fingolimod 62 tolvaptan 62 adipiplon 62 cannabinor 62 phase III isavuconazole 62 eniluracil 62 Lisofylline 62 Evista raloxifene 62 TRX1 62 histone deacetylase HDAC inhibitor 62 topically applied SEPA 62 Dose Escalation 62 Noxafil 62 Factor VIIa 62 PREOS R 62 safinamide 62 long acting muscarinic 62 Ciclesonide 62 TEMODAL 62 Eculizumab 62 HQK 62 Zybrestat 62 Loramyc R 62 #.#mg 1mg 62 Genentech Rituxan 62 Xinlay 62 Mg Uk 62 mecamylamine 62 HCV NS5B polymerase 62 entinostat 62 Actonel risedronate 62 inhibitor PPI 62 CCX# 62 candidate deforolimus 62 Pravastatin 62 mesylate 62 glucokinase activator 62 Angiotensin Converting Enzyme 62 Eli Lilly Cymbalta 62 Zerenex 62 Phase III Pivotal 62 Montelukast 62 Alvesco R 62 including eniluracil ADH 62 Squalamine 62 Demonstrated Significant 62 MYDICAR ® 62 etanercept Enbrel 62 docetaxel Taxotere ® 62 Oral NKTR 62 CRMD# 62 Solaraze 62 bucindolol hydrochloride 62 ALN TTR 62 Phase Ib study 62 pharmacodynamic properties 62 guanfacine extended release 62 CAPHOSOL R 62 SinuNase ™ 62 investigational hepatitis C 62 vemurafenib 62 Camptosar ® 62 aflibercept 62 valsartan Diovan 62 Aplidin R 62 PDX pralatrexate 62 selective androgen receptor modulators 62 IV Busulfex 62 PS# [001] 62 metformin HCl 62 compound perifosine 62 RESOLOR 62 posaconazole 62 Files IND 62 COREG CR 62 PDE# 62 Unit Dose Budesonide 62 Achieves Primary Endpoint 62 Quinamed 62 Novel Oral 62 Forteo teriparatide 62 Epratuzumab 62 MKC# 62 Lantus ® 62 Fibrin Pad 62 metformin sulfonylurea 62 mitogen activated ERK kinase 62 Cancidas 62 OMP #R# 62 tenofovir Viread 62 cangrelor 62 erlotinib Tarceva R 62 Avastin bevacizumab 62 Deforolimus 62 Migraine Drug 62 LY# [002] 62 lixisenatide 62 oral antidiabetic 62 ABILIFY ® 62 vinorelbine tartrate 62 indibulin 62 OMNARIS HFA 62 Palifosfamide 62 Indaflex TM 62 Successfully Completes Phase 62 Amlodipine Besylate 62 ATL/TV# 62 investigational antiplatelet agent 62 Presents Preclinical 62 Cethrin R 62 Levocetirizine 62 ATL# [002] 62 Pancreate 62 EXPAREL TM 62 Campath alemtuzumab 62 FTY# 62 AVE# 62 JAK3 inhibitor 62 PDUFA Date 62 orally disintegrating 62 Teriparatide 62 SARMs 62 Liposomal 62 Degarelix 62 adenosine injection 62 OMNARIS 62 Peginterferon 62 Pramlintide 62 direct thrombin inhibitors 62 histamine dihydrochloride 62 Kamada AAT 62 echinocandin 62 telomerase therapeutic 62 ralfinamide 62 relapsed multiple myeloma 62 Phase IIB 62 partial agonist 62 EXPAREL ™ 62 1mg 2mg 62 induced macular edema 62 Ocrelizumab 62 XL# anticancer compounds 62 vildagliptin 62 Dual Opioid 62 Epivir 62 Anticancer Compound 62 Zelrix 62 insulin sensitizers 62 nucleoside reverse transcriptase inhibitor 62 BENLYSTA ® 62 Adjuvant Treatment 62 polymerase inhibitor 62 Phase #b/#a clinical 62 PI3K/Akt pathway inhibitor 62 GSK '# 62 Pivotal Trial 62 CR# vcMMAE 62 Mylan Receives Approval 61 interferon gamma 1b 61 ORAL Sync 61 Nebido 61 Bevacizumab 61 MGCD# [001] 61 REG1 Anticoagulation System 61 Fibrillex 61 Cladribine 61 developing Bicifadine serotonin 61 TKB# 61 molecular imaging radiopharmaceutical 61 Everolimus 61 Ophena 61 Eribulin 61 Virulizin ® 61 oral Factor Xa 61 R sorafenib tablets 61 otelixizumab 61 Aptivus ® 61 enzastaurin 61 integrase inhibitor 61 BNC# 61 doxercalciferol 61 Vidofludimus 61 Vimpat R 61 basal insulin analogue 61 Paliperidone Palmitate 61 Tiotropium 61 Fodosine 61 Diamyd ® 61 Exherin 61 active comparator 61 XmAb# 61 mapatumumab 61 Phase IIb Clinical Trial 61 GRN# 61 bosutinib 61 Bafetinib 61 therapeutic monoclonal antibody 61 product Fentanyl TAIFUN 61 CRTX 61 HuMax CD# 61 Patient Enrolment 61 #mg/#mg 61 dextromethorphan quinidine 61 Carbidopa Levodopa 61 RezularTM 61 Cipralex ® 61 refractory gout 61 chimeric monoclonal antibody 61 DP b# 61 tacrolimus capsules 61 anti angiogenic agent 61 Crofelemer 61 Receptor Agonist 61 investigational HCV polymerase 61 GSK# [001] 61 capecitabine Xeloda 61 tarenflurbil 61 Neulasta R 61 Ceflatonin 61 desvenlafaxine 61 Exemestane 61 Exforge 61 pomalidomide 61 Femara letrozole 61 Zoledronic acid 61 orally inhaled migraine 61 BARACLUDE R 61 baminercept 61 CINQUIL 61 sulodexide 61 DAVANAT 61 TH# [003] 61 Optimer Pharma 61 multitargeted 61 Phase IIb clinical trials 61 Phase #/#a 61 darapladib 61 DPP4 61 ceftazidime 61 pseudobulbar affect PBA 61 Onalta 61 OvaRex ® MAb 61 ANAVEX #-# [003] 61 Atacand 61 Tolvaptan 61 Lovaza TM 61 somatostatin analogue 61 Interferon Beta 61 cetuximab Erbitux ® 61 lucinactant 61 CIMZIA ™ 61 Phase Ib II 61 fostamatinib 61 Abacavir 61 registrational trial 61 Cloretazine ® 61 NasalFent 61 COLAZAL R 61 Merck Januvia 61 pulmonary arterial hypertension PAH 61 docetaxel Taxotere 61 Ventavis 61 vinca alkaloid 61 Neulasta ® 61 Ereska 61 TOCOSOL Camptothecin 61 XOPENEX HFA 61 edifoligide 61 novel oral anticoagulant 61 Ezetimibe 61 Zavesca 61 torezolid 61 PEGylated 61 NDA Submission 61 mGluR2 positive 61 dopamine D2 61 KRYSTEXXA TM pegloticase 61 rALLy clinical trial 61 elvitegravir 61 CYT# QbG# 61 delta opioid receptor 61 vidofludimus 61 Vidaza azacitidine 61 GATTEX ® 61 Prilosec omeprazole 61 Olaparib 61 Topiramate 61 CYP#A# CYP#D# 61 fesoterodine 61 phase IIa 61 selective adenosine 61 irbesartan 61 Taxotere docetaxel 61 aplindore 61 Bucindolol 61 Sustiva efavirenz 61 Afatinib 61 Epothilones 61 Intravitreal 61 nitric oxide donating 61 anticancer agent 61 Keryx Biopharma 61 Vascugel 61 immunomodulating 61 Lotensin 61 Mepact 61 Rasilez 61 Sumatriptan 61 RAPTIVA 61 eprotirome 61 small molecule tyrosine 61 rNAPc2 61 Adalimumab 61 Myocet 61 Bristol Myers Squibb Pravachol 61 Campath ® 61 Loramyc 61 Cleviprex TM clevidipine 61 INCB# [003] 61 R roscovitine 61 Indomethacin 61 visilizumab 61 selective adhesion molecule 61 thetreatment 61 lapatinib Tykerb 61 Prolongs Survival 61 nalbuphine ER 61 signal transduction inhibitor 61 Emezine 61 apremilast 61 Symadex 61 Vaprisol 61 Diovan HCT 61 CoFactor 61 Increlex ® 61 EP #R 61 Otelixizumab 61 sitaxsentan 61 AOD# [002] 61 Promacta 61 allosteric modulator 61 Metastatic Melanoma 61 Certican 61 lasofoxifene 61 defensin mimetic antibiotic 61 dosing cohort 61 Levofloxacin 61 FOLFOX6 chemotherapy regimen 61 Syncria R 61 ixabepilone 61 Serdolect ® 61 OMNARIS Nasal Spray 61 M# rationally 61 Factor Xa 61 Orencia abatacept 61 Phase 1a clinical 61 Aryplase 61 targeted antifolate 61 Cloretazine VNP#M 61 YONDELIS R 61 LBH# 61 HDAC Inhibitor 61 edoxaban 61 L BLP# 61 Xarelto rivaroxaban 61 Lupuzor 61 alendronate Fosamax 61 HCV protease 61 Alkeran 61 Genz # 61 Diabetic Macular Edema 61 product candidate Lpathomab 61 methylnaltrexone 61 Tofacitinib

Back to home page